A Study to Evaluate the Long-term Safety and Tolerability of SAGE-324 in Participants With Essential Tremor

Clinical trial NCT05366751 · TERMINATED

Trial details

NCT number: NCT05366751
Sponsor: Sage Therapeutics
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Essential Tremor

Start date: 2022-06-03
Primary completion: 2024-09-10
Enrollment: 97

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.